<p>The direct-to-consumer diagnostics company built its name on longevity biomarker panels. Now it’s betting its future on everything else. Two years ago, Mito Health’s pitch was narrow and specific: order a panel of more than 100 biomarkers, skip the referral and get a longevity-minded readout on your</p>